WSJ: 'Hydroxychloroquine and Azithromycin Continue to Show Results' for Coronavirus PatientsChris MenahanInformationLiberation Mar. 30, 2020 |
'Anti-Racist' Tech CEO 'Beaten to Death by Black Male Career Criminal Who Was Released Early From Prison by Soros-Funded D.A. on Good-Time Credits'
Democrat Rep. Jaamal Bowman Caught On Video Pulling Fire Alarm to Obstruct Vote On Avoiding Shutdown
Pava LaPere Let Accused Murderer Jason Billingsley Into Her Apartment Building After He 'Acted As Though He Had Forgotten His Keys'
Dianne Feinstein, Corrupt California Senator Who Profited Off War in Iraq She Voted For, Dead at 90
Ben Shapiro Assembles Jewish Community Panel to Hector Elon Musk to Censor More on Twitter/X
![]() From The Wall Street Journal: In the fight against Covid-19 though we might look forward in doom, one day we will look backward in awe. In an article last week, I discussed a promising drug combination to treat the disease. There is now new data supporting this treatment. Since then, Kansas City area physicians, including Joe Brewer, Dan Hinthorn and me, continue to treat many patients, and some have shown improvement. Major medical centers including the University of Washington and Mass General have added hydroxychloroquine to treatment options. [...]Here's an excerpt from French microbiologist Didier Raoult's second paper: In 80 in-patients receiving a combination of hydroxychloroquine and azithromycin we noted a clinical improvement in all but one 86 year-old patient who died, and one 74 year- old patient still in intensive care unit.France 24 reports that "critics say such results were fairly typical of the virus": Two Chinese studies have shown that "10 days after the start of symptoms, 90 percent of people who have a moderate form (of the disease) have a controlled viral load," epidemiologist Dominique Costagliola, of the French health research institute Inserm, told AFP.One Arizona man died and his wife was hospitalized last week after the two took excessive amounts and overdosed on chloroquine phosphate in fish tank cleaner form. Several large-scale studies are currently being carried out in France and America to determine the drug's efficacy at both preventing and curing the virus. In the meantime, the U.S. Department of Health & Human Services announced Sunday that "the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible." Follow InformationLiberation on Twitter, Facebook, Gab and Minds. |